Berenson Most cancers Heart printed survival knowledge analyzed by the Institute for Myeloma & Bone Most cancers Analysis of 175 consecutive and unselected sufferers with a number of myeloma within the journal Haematologica.
All sufferers with a number of myeloma who began their remedy from 2006 to 2024 at Berenson Most cancers Heart, a clinic that makes a speciality of the remedy of sufferers with this frequent type of bone marrow-based most cancers, have been included within the examine.
Examine authors report a median survival of practically 13 years which is the longest reported so far in any unselected group of a number of myeloma sufferers.
Not like different myeloma facilities which think about stem cell transplant as an ordinary a part of the preliminary remedy for these sufferers, not one of the sufferers underwent this as their first remedy and just one affected person after that. Furthermore, no affected person was handled with CAR T-cell remedy or bispecific antibodies. Notably, the unprecedented outcomes on this examine have been achieved with out use of any of those therapies.
Almost 40,000 Individuals are anticipated to be identified with a number of myeloma in 2025 and 200,000 live with this most cancers.
The extremely individualized care a number of myeloma sufferers obtain contains extra remedy choices than used anyplace on the planet. Sufferers even have 24-hour direct entry to the treating doctor. Importantly, extra frequent common monitoring of the affected person’s illness standing permits for extra speedy modifications in therapies that aren’t working or inflicting undesirable unintended effects. Collectively, these advantages have resulted in unprecedented outcomes for myeloma sufferers.”
James R. Berenson, M.D., Examine Senior Creator, President & Medical Director, Berenson Most cancers Heart
Dr. Berenson has over 40 years of “hands-on” expertise caring for a number of myeloma sufferers which he believes has led to the identification of more practical therapies and experience in utilizing therapies to attain the absolute best outcomes for his sufferers.
